HDFC Bank, Lupin and Bajaj Healthcare to see some action today

06 Oct 2025 Evaluate

HDFC Bank’s average deposits were Rs 27,105 billion for the September 2025 quarter, a growth of around 15.1% over Rs 23,540 billion for the September 2024 quarter, and around 2.0% over Rs 26,576 billion for the June 2025 quarter. Its average advances under management (advances grossing up for inter-bank participation certificates, bills rediscounted and securitisation / assignment) were Rs 27,946 billion for the September 2025 quarter, a growth of around 9.0% over Rs 25,639 billion for the September 2024 quarter, and a growth of around 1.9% over Rs 27,423 billion for the June 2025 quarter.

Lupin has launched Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen, in the United States (US). Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk Inc. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with type 2 diabetes mellitus.

Bajaj Healthcare has received a positive recommendation from the Subject Expert Committee (SEC) (Neurology & Psychiatry) of the Central Drugs Standard Control Organisation (CDSCO) to initiate Phase III clinical trials for Suvorexant Tablets, available in strengths of 5mg, 10mg, 15mg, and 20mg. The company is the first company in India to receive this regulatory nod for Suvorexant. Suvorexant is a prescription medication used to treat insomnia in adults. It works by modulating the sleep-wake cycle through the central nervous system, promoting improved sleep onset and maintenance.

Ceigall India has received Letter of Award (LoA) worth Rs 597.00 crore (including GST) from Maharashtra State Electricity Distribution Co. The work order is for Solar Power Developer (SPD) for solar photovoltaic power generating stations of an aggregate capacity of 147 MW (AC) under the Mukhyamantri Saur Krushi Vahini Yojana 2.0 Scheme, for setting up grid-connected solar power projects at 2 districts in the state of Maharashtra. The work order is to be executed within 18 months and the operational period will be 25 years.

Krystal Integrated Services (KISL) has secured a contract worth around Rs 83 crore (including all duties and taxes) from Directorate of Education, New Delhi. The contract is for providing Sanitation / House Keeping Services at Government school buildings, stadium and offices under the Directorate of Education, Government of NCT of Delhi for a period of 2 years.

FDC has secured ANDA approval from United States Food and Drug Administration (U.S.FDA), for Pilocarpine Hydrochloride Ophthalmic Solution USP, 1%, 2%, and 4% (15 mL).

Hindustan Copper has executed Kendadih Mining Lease Deed with District Commissioner (DC), Jamshedpur on October 4, 2025. The company has executed 20 years Lease Deed for Kendadih Copper Mine. The deed plays a crucial role towards reopening and commencement of Copper Ore Production from the Kendadih Copper Mine, which holds strategic importance for the growth of copper production in the region.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.